BibTex RIS Cite

Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz

Year 2014, Volume: 15 Issue: 2, 116 - 123, 01.08.2014

Abstract

Objective: In this study, we aimed to present our initial results in radiofrequency ablation of kidney tumors (RFTA). Material and Methods: In 2011-2012, the data of 5 patients who underwent RFTA were evaluated. The RFTA applications were performed by ultrasound guided percutaneous technique (USG-RFTA) in 4 patients and by retroperitoneally laparoscopic technique in 1 under general anesthesia. Previously, a routine renal mass biopsy was applied. Patients were radiologically controlled at 1., 3., 6., 12. months and then annually. The presence of viable tumor at 1st month was accepted as the residue and at subsequent controls after 1st was accepted as recurrence. The presence of residual tumor at 1st control was evaluated as the failure. Results: The mean age was 65.2 ±10.2 years and the mean tumor size was 27.6±4.34 mm. 3 apllicaitons were left-sided and 2 were right-sided. One of right-sided aplication was performed in a partially nephrectomized solitary kidney. All biopsies demonstrated renal cell carcinoma. The presence of residue at 1st month control (the failure) was determined in 2(40%) USG-RFTA cases. The success rate was estimated as 60%. USG-RFTA repeated in the failed cases. Subsequently, one was controlled at 1st month and no residual tumor was determined . The other was not evaluated yet. The mean follow-up duration without any recurrence was 11.4±6.65 months. No complication related to the application was occurred. Conclusion: The RFTA application seems to be safe, less invasive and effective treatment modality in selected cases of renal tumors

References

  • Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol 2009;182(4):1271–9.
  • Lucas SM, Stern JM, Adibi M, et al. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008;179(1):75-9.
  • Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006;7(9):735-40.
  • Herr HW. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J Urol 1999;161(1):33-4.
  • Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000;163(2):442
  • Gill IS, Kavoussi LR, Lane BR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007;178(1):41-6.
  • Park H, Byun SS, Kim HH, et al. Comparison of laparoscopic and open partial nephrectomies in t1a renal cell carcinoma: a Korean multicenter experience. Korean J Urol 2010;51(7):467-71.
  • Wingo MS, Leveillee RJ. Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature 2008;22(6):1261–7. J Endourol
  • Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 1997;11(4):251-8.
  • Gervais DA, McGovern FJ, Arellano RS, et al. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005;185(1):64-71.
  • Matsumoto ED, Johnson DB, Ogan K, et al. Short- term efficacy of temperature-based radiofrequency ablation 2005;65(5):877-81. renal tumors. Urology radiofrequency stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Int J Urol 2007;14(7):585- ablation with
  • Park S, Anderson JK, Matsumoto ED, et al. Radiofrequency intermediate-term 2006;20(8):569-73. of renal J Endourol results.
  • Zagoria RJ, Traver MA, Werle DM, et al. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007;189(2):429-36.
  • Aron M, Gill IS. Renal tumor ablation. Curr Opin Urol 2005;15(5):298-305.
  • Kwan KG, Matsumoto ED. Radiofrequency ablation and cryoablation of renal tumours. Curr Oncol 2007;14(1):34-8.

Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz

Year 2014, Volume: 15 Issue: 2, 116 - 123, 01.08.2014

Abstract

Amaç: Bu çalışmada böbrek tümörü tanısıyla yaptığımız radyofrekans tümör ablasyonu (RFTA) uygulamasındaki ilk deneyimlerimizi sunmayı amaçladık. Gereç ve Yöntem: 2011-2012 yıllarında böbrek tümörü tanısıyla RFTA yapılan 5 hastanın verileri değerlendirildi. RFTA işlemi, 4 hastada ultrason klavuzluğunda (USG-RFTA) ve 1 hastada retroperitoneal teknikle laparoskopi eşliğinde (L-RFTA) genel anestezi altında gerçekleştirildi. RFTA öncesi rutin renal kitle biyopsisi yapıldı. Hastalar işlem sonrası 1, 3, 6 ve 12. aylarda ve sonrasında yılda bir kontrastlı radyolojik görüntüleme teknikleri ile kontrol edildi. 1. ay kontrolde canlı tümör dokusu varlığı rezidü ve ilk ay kontrolü normal olup sonraki aylarda saptanan canlı (kontrastlanan) tümör dokusu nüks olarak değerlendirildi. 1. ay kontrolde rezidü varlığı da başarısızlık olarak kabul edildi. Bulgular: Ortalama yaş 65,2 ±10,2 yıl ve ortalama tümör boyutu 27,6±4,34 mm bulundu. İşlemlerin 3’ü sol ve 2’si sağ tarafa uygulanmıştır. Sağ taraf işlemlerinden biri sağ parsiyel nefrektomili soliter böbreğe yapılmıştır. Tüm biyopsi patolojileri renal hücreli kanser olarak bulundu. İki (%40) USG-RFTA olgusunda 1. ay kontrolde rezidü varlığı (başarısızlık) gözlendi. İşlem başarısı %60 olarak belirlendi. Başarısızlık gözlenen 2 olguya USG-RFTA tekrarı yapıldı. Takiben kontrolü yapılan 1 olgunun ilk ay kontrolünde rezidü saptanmazken, diğer olgunun kontrolü henüz yapılmamıştır. Ortalama takip süresi 11,4±6,65 ay olup, bu süre içinde hiçbir olguda nüks gözlenmemiştir. Hiçbir hastada uygulamaya bağlı komplikasyon gözlenmemiştir. Sonuç: RTFA işlemi seçilmiş böbrek tümörlerinin tedavisinde güvenli, daha az invaziv ve etkili bir tedavi yöntemi olarak görünmektedir

References

  • Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol 2009;182(4):1271–9.
  • Lucas SM, Stern JM, Adibi M, et al. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008;179(1):75-9.
  • Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006;7(9):735-40.
  • Herr HW. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J Urol 1999;161(1):33-4.
  • Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000;163(2):442
  • Gill IS, Kavoussi LR, Lane BR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007;178(1):41-6.
  • Park H, Byun SS, Kim HH, et al. Comparison of laparoscopic and open partial nephrectomies in t1a renal cell carcinoma: a Korean multicenter experience. Korean J Urol 2010;51(7):467-71.
  • Wingo MS, Leveillee RJ. Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature 2008;22(6):1261–7. J Endourol
  • Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 1997;11(4):251-8.
  • Gervais DA, McGovern FJ, Arellano RS, et al. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005;185(1):64-71.
  • Matsumoto ED, Johnson DB, Ogan K, et al. Short- term efficacy of temperature-based radiofrequency ablation 2005;65(5):877-81. renal tumors. Urology radiofrequency stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Int J Urol 2007;14(7):585- ablation with
  • Park S, Anderson JK, Matsumoto ED, et al. Radiofrequency intermediate-term 2006;20(8):569-73. of renal J Endourol results.
  • Zagoria RJ, Traver MA, Werle DM, et al. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007;189(2):429-36.
  • Aron M, Gill IS. Renal tumor ablation. Curr Opin Urol 2005;15(5):298-305.
  • Kwan KG, Matsumoto ED. Radiofrequency ablation and cryoablation of renal tumours. Curr Oncol 2007;14(1):34-8.
There are 15 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Mehmet Bilgehan Yüksel This is me

Bilal Gümüş This is me

Erdem Özbek This is me

Ayhan Karaköse This is me

Serdar Tarhan This is me

Gökhan Temeltaş This is me

Talha Müezzinoğlu This is me

Publication Date August 1, 2014
Published in Issue Year 2014 Volume: 15 Issue: 2

Cite

APA Yüksel, M. B., Gümüş, B., Özbek, E., Karaköse, A., et al. (2014). Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz. Kocatepe Tıp Dergisi, 15(2), 116-123. https://doi.org/10.18229/ktd.43176
AMA Yüksel MB, Gümüş B, Özbek E, Karaköse A, Tarhan S, Temeltaş G, Müezzinoğlu T. Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz. KTD. August 2014;15(2):116-123. doi:10.18229/ktd.43176
Chicago Yüksel, Mehmet Bilgehan, Bilal Gümüş, Erdem Özbek, Ayhan Karaköse, Serdar Tarhan, Gökhan Temeltaş, and Talha Müezzinoğlu. “Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz”. Kocatepe Tıp Dergisi 15, no. 2 (August 2014): 116-23. https://doi.org/10.18229/ktd.43176.
EndNote Yüksel MB, Gümüş B, Özbek E, Karaköse A, Tarhan S, Temeltaş G, Müezzinoğlu T (August 1, 2014) Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz. Kocatepe Tıp Dergisi 15 2 116–123.
IEEE M. B. Yüksel, B. Gümüş, E. Özbek, A. Karaköse, S. Tarhan, G. Temeltaş, and T. Müezzinoğlu, “Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz”, KTD, vol. 15, no. 2, pp. 116–123, 2014, doi: 10.18229/ktd.43176.
ISNAD Yüksel, Mehmet Bilgehan et al. “Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz”. Kocatepe Tıp Dergisi 15/2 (August 2014), 116-123. https://doi.org/10.18229/ktd.43176.
JAMA Yüksel MB, Gümüş B, Özbek E, Karaköse A, Tarhan S, Temeltaş G, Müezzinoğlu T. Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz. KTD. 2014;15:116–123.
MLA Yüksel, Mehmet Bilgehan et al. “Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz”. Kocatepe Tıp Dergisi, vol. 15, no. 2, 2014, pp. 116-23, doi:10.18229/ktd.43176.
Vancouver Yüksel MB, Gümüş B, Özbek E, Karaköse A, Tarhan S, Temeltaş G, Müezzinoğlu T. Böbrek Tümörlerinde Minimal İnvaziv Tedavi: Radyofrekans Ablasyon İlk Deneyimlerimiz. KTD. 2014;15(2):116-23.

88x31.png
Bu Dergi Creative Commons Atıf-GayriTicari-AynıLisanslaPaylaş 4.0 Uluslararası Lisansı ile lisanslanmıştır.